Searchable abstracts of presentations at key conferences in endocrinology

ea0095p70 | Pituitary and Growth 1 | BSPED2023

Novel insights into genetic causes of childhood growth failure from patients recruited to the 100 000 Genomes Project

Ishida Miho , Vestito Letizia , Maharaj Avinaash , Cipriani Valentina , Smedley Damian , Storr Helen

Short stature (SS), defined as height ≤−2 SDS for a given population, comprises ~50% of new patient referrals to paediatric endocrine clinics. Since >80% SS children in the UK do not receive a clear diagnosis, enhanced genetic testing and stratification is a fundamental need. Whole-genome sequencing (WGS) was offered to rare disease patients recruited to the 100 000 Genomes Project (100KGP), leading to new clinical diagnoses in ~25% of participants. The 100KGP ...

ea0099ep253 | Reproductive and Developmental Endocrinology | ECE2024

Characterization of liver abnormalities in a population of adult turner women: results from an observational study

Cecchetti Carolina , Rotolo Laura , Dionese Paola , Belardinelli Elisabetta , Solmi Beatrice , Vestito Amanda , Dajti Elton , Colecchia Antonio , Pagotto Uberto , Gambineri Alessandra

Introduction: Liver function test abnormalities (LFA) are common in patients with Turner syndrome (TS). The etiopathogenesis of this complication remains unclear, probably being multifaceted. Metabolic syndrome, generalized vasculopathy, and autoimmunity have been proposed as possible causal mechanisms.Objectives: - To describe the prevalence and possible related factors of morpho-functional liver abnormalities in TS adult patients. - To evaluate the uti...

ea0056oc14.1 | What is new in gestational and type 1 diabetes? | ECE2018

Does insulin treatment differ in their impact on placental vascular circulation in obese and non obese women with gestational diabetes mellitus?

Shargorodsky Marina , Barda Gulia , Bar Jacob , Shraiber Letizia

Objective: The present study was designed to investigate the impact of insulin treatment on placental maternal and fetal vascular circulation in obese and non-obese women with gestational diabetes mellitus (GDM).Design and methods: One hundred and ninety two women with GDM who gave birth and underwent a placental histopathological examination at Wolfson Medical Center were included in the study: 123 women who were treated with diet (Group 1) and 69 women...

ea0081p526 | Adrenal and Cardiovascular Endocrinology | ECE2022

Testosterone, hypogonadism, and heart failure: a systematic and critical review

Di Lodovico Elena , Facondo Paolo , Delbarba Andrea , Chiara Pezzaioli Letizia , Maffezzoni Filippo , Cappelli Carlo , Ferlin Alberto

Background: Male hypogonadism is defined by low circulating testosterone level associated with signs and symptoms of testosterone deficiency. Although the bidirectional link between hypogonadism and cardiovascular disease has been clarified recently, the association between testosterone and chronic heart failure (CHF) is more controversial. Methods: We critically review published studies relating to testosterone, hypogonadism, and CHF and provide practic...

ea0081p127 | Endocrine-Related Cancer | ECE2022

Role of DKK1 in growth and migration of prostate cancer cells

Rinella Letizia , Compagno Mara , Fiorentino Gloria , Fortunati Nicoletta , Arvat Emanuela , Catalano Maria Graziella

Androgen deprivation therapy is the choice treatment of metastatic prostatic tumors. Unfortunately, very often, resistance occurs and chemotherapy is needed. Results are however disappointing with frequent side effects. Therefore, new therapeutic approaches for metastatic and advanced prostate cancer are necessary. DKK1, an inhibitor of the Wnt signaling pathway, is increased in different types of cancer. In prostate cancer patients with bone metastases, an increase of DKK1 is...

ea0081p441 | Reproductive and Developmental Endocrinology | ECE2022

Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism

Facondo Paolo , Di Lodovico Elena , Chiara Pezzaioli Letizia , Cappelli Carlo , Ferlin Alberto , Delbarba Andrea

Objective: To investigate whether routine assessment of free testosterone improves the diagnostic accuracy of functional male hypogonadism.Methods: Total and free testosterone (calculated through SHBG assessment) were determined in 372 male patients (median age 44) referring to our department for sexual symptoms symptoms (188 patients) or infertility (184 men). Low total and free testosterone were defined as < 2.31 ng/ml and <63 pg/ml, respective...

ea0081ep754 | Pituitary and Neuroendocrinology | ECE2022

Early diagnostic tools in milder forms of central hypothyroidism in patients harbouring a pituitary adenoma: cross-sectional study on 142 patients from a single tertiary center

Galazzi Elena , Nicoli Federico , Carrara Silvia , Milan Chiara , Fatti Letizia Maria , Moro Mirella , Persani Luca

Introduction: Milder forms of central hypothyroidism (CeH) are still challenging to diagnose due to absence of gold standards, wide variability of fT4 values and aspecificity of symptoms. We aimed to find diagnostic clues at diagnosis (pituitary lesion dimensions, other hormonal deficit) and during long-term follow-up, guiding the clinician to a precocious diagnosis of CeH.Study: 142 patients harbouring a pituitary adenoma with complete pituitary assessm...

ea0090p143 | Pituitary and Neuroendocrinology | ECE2023

Role of fT4 and TSH-index fluctuations as early diagnostic tools in milder forms of central hypothyroidism: data from 221 patients with pituitary lesions from a single tertiary center

Carrara Silvia , Galazzi Elena , Nicoli Federico , Moro Mirella , Fatti Letizia , Cangiano Biagio , Persani Luca

Diagnosis of Central Hypothyroidism (CeH) is commonly given when FT4 concentrations are below the lower limit of normal range. A reduction in FT4 concentrations greater than 20% was proposed in ETA 2018 Guidelines as an unphysiological fluctuation indicating the onset of milder forms of CeH with FT4 still within the normal range. Similarly, TSH-index was proposed to quantify thyrotrope reserve, hence as a tool to detect patients at risk of CeH. Here we verified the performance...

ea0065p183 | Metabolism and Obesity | SFEBES2019

Hepatic effects of new anti-diabetic drugs: real world data from a retrospective study

Colosimo Santo , Brodosi Lucia , Marchignoli Francesca , Barbanti Francesca A , Marchesini Giulio , Petroni Maria Letizia

Background and aims: There is evidence that new anti-diabetic drugs may limit liver disease progression, reduce liver fat and normalize serum aminotranferase levels in patients with NAFLD. We compared the effectiveness of new drug classes on liver fat in T2DM patients by means of surrogate markers.Materials and methods: In an observational retrospective study we analysed the 12-month time-courses of clinical and anthropometric data of T2DM cases treated ...

ea0040oc5 | (1) | ESEBEC2016

The anti-proliferative effect of metformin in a model of adrenocortical carcinoma

Armignacco Roberta , Poli Giada , Cantini Giulia , Canu Letizia , Mannelli Massimo , Luconi Michaela

Adrenocortical carcinoma (ACC) is a rare, heterogeneous malignancy with aggressive behavior and poor prognosis, particularly when metastatic at diagnosis. To date, radical surgery, possibly associated to mitotane adjuvant therapy, is considered the best option for ACC treatment. However, the mean 5-year survival rate diminishes dramatically in metastatic ACC and chemo-resistance often develops. Thus, more specific and effective drugs for ACC treatment are urgently required. Th...